Ambler, PA, United States of America

Yin Liang

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.3

ph-index = 1


Location History:

  • Owings Mills, MD (US) (2012)
  • Ambler, PA (US) (2019 - 2023)

Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Yin Liang in Diabetes Treatment

Introduction

Yin Liang, an accomplished inventor based in Ambler, PA, has made significant contributions to the field of pharmaceutical science. With a total of four patents to her name, she focuses primarily on innovative treatments for diabetes and related disorders. Her work at Janssen Pharmaceutica NV showcases her commitment to advancing healthcare through groundbreaking inventions.

Latest Patents

Yin Liang's latest patents reflect her focus on innovative therapies for diabetes. The first patent addresses a combination therapy for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. It encompasses co-therapy methods and pharmaceutical compositions designed to improve patient outcomes.

Her second patent features benzocyclobutane derivatives that work as dual SGLT1/SGLT2 modulators. This invention includes pharmaceutical compositions containing these derivatives, which are effective in treating disorders associated with SGLT activity, specifically Type II diabetes mellitus and its complications.

Career Highlights

Throughout her career, Yin Liang has consistently aimed to develop cutting-edge treatments for metabolic disorders. Her work has not only garnered patents but has also contributed to the understanding of diabetes management in clinical settings. She plays an integral role at Janssen Pharmaceutica NV, where her research is applied to create life-changing pharmaceutical solutions.

Collaborations

Yin Liang collaborates with various talented professionals within her field, including notable coworkers Keith T. Demarest and Michael D. Gaul. These partnerships have helped amplify her impact in the pharmaceutical industry and foster innovative approaches in diabetes treatment.

Conclusion

Yin Liang's pioneering inventions and her continued work at Janssen Pharmaceutica NV demonstrate her vital role in addressing diabetes and glucose-related disorders. With her focus on effective treatment methods and collaboration with skilled colleagues, she remains a key figure in the innovation landscape of pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…